Yeomans Consulting Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$213K Buy
+198
New +$189K 0.06% 111
2024
Q3
Sell
-255
Closed -$231K 93
2024
Q2
$231K Buy
+255
New +$204K 0.09% 82
2024
Q1
Sell
-876
Closed -$511K 79
2023
Q4
$511K Buy
+876
New +$511K 0.25% 36

Other funds holding LLY

Yeomans Consulting Group's LLY Position: Q4 2025 in Review

Yeomans Consulting Group opened a new position in Eli Lilly (LLY) in Q4 2025: 198 shares worth $213K. The stake represents 0.06% of the portfolio and ranks #111 among its holdings. This is a return to the name: Yeomans Consulting Group previously reported a position in LLY as recently as Q2 2024.

Yeomans Consulting Group first reported a position in LLY in Q4 2023 and has held it in 3 quarters since. The position peaked at $511K in Q4 2023. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Yeomans Consulting Group held 198 shares of Eli Lilly worth $213K as of Q4 2025.
  • Eli Lilly was a new Yeomans Consulting Group position in Q4 2025.
  • Eli Lilly made up 0.06% of Yeomans Consulting Group's portfolio in Q4 2025, its #111 holding.
  • Yeomans Consulting Group first reported a position in Eli Lilly in Q4 2023 and has held it in 3 quarters since.
  • Yeomans Consulting Group's Eli Lilly position peaked at $511K in Q4 2023.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Yeomans Consulting Group's 13F filing for Q4 2025, filed 7 Jan 2026.